Pacer Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $188K | Sell |
|
|||||
|
2025
Q2 | $165K | Sell |
|
|||||
|
2025
Q1 | $159K | Buy |
|
|||||
|
2024
Q4 | $221K | Buy |
|
|||||
|
2024
Q3 | $174K | Sell |
|
|||||
|
2024
Q2 | $158K | Sell |
|
|||||
|
2024
Q1 | $144K | Sell |
|
|||||
|
2023
Q4 | $110K | Buy |
|
|||||
|
2023
Q3 | $105K | Buy |
|
|||||
|
2023
Q2 | $68.9K | Buy |
|
|||||
|
2023
Q1 | $76.1K | Buy |
|
|||||
|
2022
Q4 | $75.9K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $68K | Sell |
|
|||||
|
2021
Q3 | $86K | Buy |
|
|||||
|
2021
Q2 | $85K | Hold |
|
|||||
|
2021
Q1 | $99K | Sell |
|
|||||
|
2020
Q4 | $87K | Sell |
|
|||||
|
2020
Q3 | $100K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $82K | Buy |
|
|||||
|
2019
Q3 | $36K | Buy |
|
|||||
|
2019
Q2 | $32K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1.66M | Buy |
|
|||||
|
2017
Q4 | $1.31M | Buy |
|
|||||
|
2017
Q3 | $702K | Buy |
|
|||||
|
2017
Q2 | $1.26M | Buy |
|
|||||
|
2013
Q4 | $459K | Buy |
|